Active Government Funding Opportunities

The Army seeks orthopaedic clinical research to advance musculoskeletal injury treatment and recovery for military personnel. This award funds innovative studies addressing combat-related and service-connected orthopaedic conditions.

DoD supports investigator-initiated neurofibromatosis research across all phases (excluding clinical trials) to advance understanding of NF disorders and improve patient care. Projects may leverage open science collaboration and qualified researcher partnerships to accelerate breakthroughs.

Fund continuation of military medical R&D projects ranging from late-stage preclinical to clinical research that address Service Member health needs. Supports pharmaceutical, biologic, medical device, and technology development through clinical trials and translational studies.

The Army seeks applied research innovations in orthopaedic medicine to advance soldier health and readiness. This award funds development of new treatments, devices, or technologies addressing musculoskeletal injuries and combat-related orthopedic conditions.

DoD seeks groundbreaking novel concepts to advance rare cancer research and treatment. This concept award supports highly innovative, untested ideas without requiring preliminary data, enabling early-stage exploration of potentially transformative approaches.

Develop research resources, datasets, and infrastructure to advance rare cancers research and treatment outcomes. Supports patient tissue repositories, tumor models, data-sharing platforms, and community engagement strategies.

Support innovative research to understand and cure bone marrow failure diseases through scientifically sound approaches. Open to established and early-career investigators; preliminary data not required.

This DoD funding supports early-stage rare cancer research ideas with potential for high-impact discoveries. The program welcomes exploratory approaches and accepts preliminary data from related disease studies to advance novel investigation pathways.

DoD seeks groundbreaking, untested concepts to open entirely new research avenues in kidney cancer. This high-risk award supports innovative theories and basic research with potential to transform the field, requiring no preliminary data.

DOJ's Byrne Discretionary Grants fund projects that strengthen criminal justice systems, prevent juvenile delinquency, and support crime victims. This congressionally designated funding supports proven approaches across law enforcement, youth intervention, and victim services.

NTIA is funding broadband infrastructure expansion and digital service adoption on Tribal lands, supporting remote learning, telework, and telehealth access. This grant program helps eligible tribal entities bridge the digital divide in underserved communities.

DoD seeks to develop new investigators in post-traumatic epilepsy research through a virtual research center offering mentoring, networking, and collaboration. The program aims to expand the PTE research field by supporting faculty with career guidance and peer support.

Combat cyber scams and human trafficking in Vietnam by training young professionals to develop innovative cybersecurity solutions. The program equips participants aged 18-30 with emerging tech skills to create practical defenses against transnational fraud operations targeting Americans and Vietnamese citizens.

DoD seeks experienced leadership to direct a virtual post-traumatic epilepsy research center, mentoring new investigators and building a collaborative network to advance PTE research quality and expand the field.

Support early-career researchers conducting innovative autism studies and proof-of-principle clinical trials. This award funds high-impact research ideas with required community partnership to advance autism understanding and treatment.

This DoD award funds basic, translational, and clinical research to understand post-traumatic epilepsy by repurposing existing research cohorts, tools, or resources. It accelerates discovery by applying established resources to a new medical challenge.

This DoD program funds collaborative research partnerships tackling post-traumatic epilepsy (PTE), requiring at least two investigators with complementary expertise to synergistically address critical scientific questions that individual efforts couldn't achieve.

DoD seeks novel research on post-traumatic epilepsy and related conditions to improve outcomes for Service Members and Veterans. Awards support creative new research directions that challenge existing paradigms, open to investigators at all career levels.

DoD seeks innovative, high-risk autism research to accelerate discoveries and improve outcomes for autistic individuals. This award supports novel ideas with potential to generate impactful data and open new investigation pathways.

This Army funding opportunity supports investigator-initiated research into toxic exposures affecting military personnel, seeking novel scientific studies to understand health impacts and inform prevention strategies.

This Army Medical Research Acquisition Activity (USAMRAA) award supports physician-led research to advance prostate cancer prevention, detection, and treatment. It funds innovative scientific investigations addressing this significant military and public health challenge.

This Army research award supports early-stage investigators studying prostate cancer biology, prevention, or treatment. It funds novel scientific research to advance understanding and clinical outcomes for this disease.

This award funds translational research bridging discoveries in traumatic brain injury (TBI) and psychological health toward clinical applications. Research aims to advance understanding and treatment of TBI-related mental health conditions in military populations.

The Army seeks innovative melanoma research proposals to advance understanding of this deadly cancer and improve prevention, detection, and treatment strategies. This program funds early-stage ideas with potential to transform melanoma care and soldier health outcomes.

This Army award supports melanoma survivorship research, focusing on improving quality of life and long-term outcomes for cancer survivors. It seeks studies addressing post-treatment complications, psychosocial factors, and evidence-based interventions for melanoma patients.